Prelude Therapeutics (PRLD) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Prelude Therapeutics

    NASDAQ: PRLD · Real-Time Price · USD
    1.19
    0.00 (0.00%)
    At close: Sep 10, 2025, 3:59 PM
    1.19
    0.00%
    After-hours: Sep 10, 2025, 04:10 PM EDT

    Prelude Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -0.76 -2.12 -2.67 -5.35
    PEG Ratio
    		 0.04 0.19 1.04 -0.07
    PS Ratio
    		 13.75 n/a n/a n/a
    PB Ratio
    		 0.73 1.09 1.46 2.07
    P/FCF Ratio
    		 -0.93 -2.33 -3.3 -6.9
    P/OCF Ratio
    		 -0.94 -2.41 -3.42 -7.09
    OCF/S Ratio
    		 -14.7 n/a n/a n/a
    Debt / Equity Ratio
    		 0.14 0.07 0.01 0.01
    Quick Ratio
    		 5.30 10.79 9.42 15.37
    Current Ratio
    		 5.30 10.79 9.42 15.37
    Asset Turnover
    		 0.04 n/a n/a n/a
    Interest Coverage
    		 n/a n/a n/a n/a
    Return on Equity
    		 -0.97 -0.51 -0.55 -0.39
    Return on Assets
    		 -0.72 -0.44 -0.49 -0.36
    Return on Invested Capital
    		 -0.9 -0.51 -0.57 -0.39
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 1.00 n/a n/a n/a
    Net Profit Margin
    		 -18.17 n/a n/a n/a
    Pretax Profit Margin
    		 -18.17 n/a n/a n/a
    Operating Profit Margin
    		 -19.96 n/a n/a n/a
    FCF Margin
    		 -14.81 n/a n/a n/a
    EBITDA Margin
    		 -19.96 n/a n/a n/a

    Add to Watchlist